Finance

Beta
Lists
IMRX:NASDAQ
Immuneering Corp
၄.၆၀ US$
+၁.၃၂%
(+၀.၀၆၀) 1D
၄.၅၉ US$
-၀.၂၂% (-၀.၀၁၀၀)
Pre-market
Closed: ဇွန် ၂၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
၄.၆၀ US$
High
၄.၆၅ US$
Low
၄.၅၂ US$
Mkt. cap
၂၉.၆၃ ကုဋေ
Avg. vol.
၁.၉၂ သန်း
Volume
၁.၇၆ ထောင်
52-wk high
၁၀.၀၈ US$
52-wk low
၂.၈၇ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၈
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
Open
၄.၆၀ US$
High
၄.၆၅ US$
Low
၄.၅၂ US$
Mkt. cap
၂၉.၆၃ ကုဋေ
Avg. vol.
၁.၉၂ သန်း
Volume
၁.၇၆ ထောင်
52-wk high
၁၀.၀၈ US$
52-wk low
၂.၈၇ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၈
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
News stories
From sources across the web
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၈ နာရီ
Top Executive Makes Bold Insider Move on Immuneering Stock
Investing.com Nigeria
Investing.com Nigeria
·
ပြီးခဲ့သည့် ၉ နာရီ
Form 4 Immuneering Corp For: 24 June By Investing.com
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၉ နာရီ
Immuneering CEO Zeskind buys $10,948 in stock By Investing.com
About Immuneering Corp
CEO-
Employees၅၅
Founded၂၀၀၈
Headquarters-
Sector-
Websiteimmuneering.com
Analyst Ratings
Based on 4 analysts giving stock ratings to IMRX in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current ၄.၆၀ US$
၂၀.၀၀ US$ (+၃၃၄.၇၈%)
Average
၁၃.၇၅ US$ (+၁၉၈.၉၁%)
Lowest
၁၁.၀၀ US$ (+၁၃၉.၁၃%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
၁၂.၀၀ US$
+၁၆၀.၉%
06/16/2026
Ami Fadia
Needham
Buy
Maintained
၁၁.၀၀ US$
+၁၃၉.၁%
06/02/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
၂၀.၀၀ US$
+၃၃၄.၈%
05/19/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
၁၂.၀၀ US$
+၁၆၀.၉%
04/21/2026
Jay Olson
Oppenheimer
Buy
Reiterated
၃၀.၀၀ US$
+၅၅၂.၂%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၀၅ ကုဋေ
၁.၀၉ ကုဋေ
၉.၂၅ သန်း
၁.၀၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၃၀ သန်း
၄.၅၁ သန်း
၄.၄၉ သန်း
၄.၆၈ သန်း
Operating expense
၁.၄၈ ကုဋေ
၁.၅၄ ကုဋေ
၁.၃၈ ကုဋေ
၁.၅၃ ကုဋေ
Total operating expenses
၁.၄၈ ကုဋေ
၁.၅၄ ကုဋေ
၁.၃၈ ကုဋေ
၁.၅၃ ကုဋေ
Operating income
-၁.၄၈ ကုဋေ
-၁.၅၄ ကုဋေ
-၁.၃၈ ကုဋေ
-၁.၅၃ ကုဋေ
Other non operating income
-
-
၁.၅၆ သိန်း
၁.၀၉ သိန်း
EBT including unusual items
-၁.၄၄ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၁၆ ကုဋေ
-၁.၃၅ ကုဋေ
EBT excluding unusual items
-၁.၄၄ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၁၇ ကုဋေ
-၁.၃၉ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၄၄ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၁၆ ကုဋေ
-၁.၃၅ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၄၀
-၀.၃၈
-၀.၁၈
-၀.၂၁
Interest and investment income
၃.၂၄ သိန်း
၄.၁၆ သိန်း
၁.၈၆ သန်း
၁.၃၆ သန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၂၄ သိန်း
၄.၁၆ သိန်း
၁.၈၆ သန်း
၁.၃၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၄၇ ကုဋေ
-၁.၅၃ ကုဋေ
-၁.၃၇ ကုဋေ
-၁.၅၂ ကုဋေ
Gain or loss from assets sale
-
-
၂.၀၉ ထောင်
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer